$485.39
-11.11-2.24%
At close: Jul 10, 5:00 PM EST
$487.29
1.900.39%
After Hours: Jul 10, 7:21 PM EST
Vertex Pharmaceuticals Inc Earnings Estimates
VRTXNASDAQ
Vertex Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VRTX
Vertex Pharmaceuticals (VRTX) is scheduled to report Q2 earnings on August 3, 2026. Analysts estimate EPS of $4.63 and quarterly revenue of $3.21B.
In the most recent quarter (Q1), Vertex Pharmaceuticals reported EPS of $4.47, beating estimates of $4.18 by 0.07%. Revenue came in at $2.99B, missing the estimate of $2.99B by 0.00%.
Vertex Pharmaceuticals has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Vertex Pharmaceuticals has averaged an EPS surprise of 0.08% and a revenue surprise of 0.01%.
Earnings Date
Aug 3
EPS Estimate
$4.630
Quarterly Revenue Estimate
$3.21B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$12.22B
Vertex Pharmaceuticals Earnings History
Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Vertex Pharmaceuticals (VRTX) Earnings Per Share
The chart below shows Vertex Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Vertex Pharmaceuticals (VRTX) Revenue
The chart below shows Vertex Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?
Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on August 3, 2026. The last reported earnings were for reported on May 4, 2026 for Q1.
What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?
The Actual EPS was $4.47, which beat the estimate of $4.18.
What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?
The Actual Revenue was $2.99B, which missed the estimate of $2.99B.
